about
HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV InfectionHSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York CityWill "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City?Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis.Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for preventionUse of the "NYC Condom" among people who use drugs.Public funding of US syringe exchange programs.Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventionsWhat's community got to do with it? Implementation models of syringe exchange programsDoing harm reduction better: syringe exchange in the United States.Respondent-driven sampling in a study of drug users in New York City: notes from the field.Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenanceHIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City.Gender and age patterns in HSV-2 and HIV infection among non-injecting drug users in New York City.Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for "Ending the Epidemic"Epidemiology of pain among outpatients in methadone maintenance treatment programs.Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study.Perceptions of drug users regarding hepatitis C screening and care: a qualitative study
P50
Q28534118-07487893-511E-4D0E-B9EA-1AA2172D7417Q28539412-830DEBDC-CA81-41E5-96BC-F397B89A1ADBQ28547185-A87F9815-2782-4621-A658-71476F0069D8Q30406126-30F2AA62-9B90-46DF-96E7-DE28AD733049Q33707925-3862D904-9ABA-44D2-999A-7AD1AB9D5D87Q33818262-AB7864EF-8398-467C-B499-5C8D3F8C1B43Q34309133-F6FCA49F-59C0-496B-BF8C-797E6C5B5B53Q34765548-B860E877-BC54-418B-8517-D37E771F2731Q34795098-B431D6D6-17DA-4C37-A25E-7C18370F782BQ34944380-13DB30AB-AF31-44D2-A99C-79AECE8EA6B5Q35230089-19F721ED-3D0E-41C3-93CE-36EEF6355D93Q35336367-038EA357-1DA9-4263-9DC5-9B367CAAD10FQ35659939-B988E1C8-9B52-4EB7-B752-AD23F39F7DCFQ35671191-2CBF2661-A099-4377-87F3-AD31CE2C7414Q35683923-729586C9-BED1-4DF9-A9D5-DEEC263F0237Q35690302-349FF345-49CE-4CB8-8E72-F4BA5592389AQ36025521-DBE96887-7652-4296-A59E-7CCAF9432F7AQ36536405-090B579B-34E0-4A2D-B818-A814BD162AA8Q36856070-E838028C-CBB4-4A5E-A4B3-BD91529B8D20Q36964408-877B7EB6-EA0C-4A49-85E9-4E3B3F40588B
P50
description
onderzoeker
@nl
name
Courtney McKnight
@ast
Courtney McKnight
@en
Courtney McKnight
@es
Courtney McKnight
@nl
Courtney McKnight
@sl
type
label
Courtney McKnight
@ast
Courtney McKnight
@en
Courtney McKnight
@es
Courtney McKnight
@nl
Courtney McKnight
@sl
prefLabel
Courtney McKnight
@ast
Courtney McKnight
@en
Courtney McKnight
@es
Courtney McKnight
@nl
Courtney McKnight
@sl